Research compound supplied in Australia by Pulse Biolabs. Available in 5mg, 10mg, 15mg, 20mg, 30mg.
Most compounds in this category act on a single receptor. Retatrutide was engineered to act on three at once.
Retatrutide, development code LY3437943, is a single synthetic peptide conjugated to a fatty diacid moiety. It acts as an agonist at three receptors simultaneously: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon.
Read the full research note →Every batch is supplied with third-party analytical testing. Third-party test results are provided for informational purposes only. Pulse Biolabs undertakes rigorous verification of all testing data against batch records through independent sources; results are representative of the manufacturer batch but may not reflect every individual sample. For research use only.
View Retatrutide test documents →
Lyophilised material is stored refrigerated and protected from light. Reconstitution requires bacteriostatic water, which is listed separately under Essentials. Once reconstituted, material is kept refrigerated.
| Presentation | Code | Status | Price |
|---|---|---|---|
| 5mg | RT5 | In stock | $70 |
| 10mg | RT10 | In stock | $100 |
| 15mg | RT15 | In stock | $140 |
| 20mg | RT20 | In stock | $175 |
| 30mg | RT30 | In stock | $250 |